Histone Deacetylase Inhibitors in Combinatorial Anticancer Therapy
Ganai, Shabir Ahmad
Produktnummer:
18c2e7211413064eafb124c83e902b1fda
| Autor: | Ganai, Shabir Ahmad |
|---|---|
| Themengebiete: | Anticancer therapy Combinatorial therapy HDAC inhibitors Histone deacetylase Therapeutic Intervention gene expression |
| Veröffentlichungsdatum: | 24.11.2021 |
| EAN: | 9789811581816 |
| Sprache: | Englisch |
| Seitenzahl: | 258 |
| Produktart: | Kartoniert / Broschiert |
| Verlag: | Springer Singapore |
Produktinformationen "Histone Deacetylase Inhibitors in Combinatorial Anticancer Therapy"
This book reviews the latest developments in the design, synthesis, and molecular mechanism of action of Histone Deacetylase (HDAC) inhibitors in the context of potential cancer therapy. HDAC inhibitors are emerging as promising anticancer drug molecules that promote growth arrest, differentiation and apoptosis of cancer cells with tumor selective toxicity.The book begins with an overview of various epigenetic modifying enzymes that are involved in cancer transition and progression; before exploring the potential of HDACs in cancer treatment. It provides a classification of HDAC inhibitors based on their structural attributes, and addresses HDAC-induced cytotoxicity..Lastly, it discusses and assesses the rationale behind therapies that combine HDAC inhibitors with other anticancer agents to treat solid tumors. Given its scope, it offers a valuable resource for all researchers, clinicians, and students working in formulation, drug discovery, oncology, and personalized medicine.
Sie möchten lieber vor Ort einkaufen?
Sie haben Fragen zu diesem oder anderen Produkten oder möchten einfach gerne analog im Laden stöbern? Wir sind gerne für Sie da und beraten Sie auch telefonisch.
Juristische Fachbuchhandlung
Georg Blendl
Parcellistraße 5 (Maxburg)
8033 München
Montag - Freitag: 8:15 -18 Uhr
Samstags geschlossen